期刊文献+

连续性肾脏替代治疗对急性肾功能衰竭患者血浆细胞因子的影响 被引量:1

Effect of continuous renal replacement therapy on the plasma cytokine in patients with acute renal failure
原文传递
导出
摘要 目的探讨连续性肾脏替代治疗(CRRT)对急性肾功能衰竭(ARF)患者血浆细胞因子的影响。方法对42例急性肾功能衰竭患者进行CRRT治疗,使用ELISA法检测治疗前和治疗后4、12、24、48 h血浆肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、IL-6、IL-8的浓度,并与同期健康人群做比较。结果 ARF患者TNF-α、IL-1β、IL-6、IL-8血浆浓度均显著高于正常对照组(P<0.01),4种细胞因子在CRRT治疗4 h开始后显著下降,12 h时浓度降至最低,24~48 h有不同程度的回升,但仍低于治疗前水平。结论 CRRT能有效清除ARF患者血浆细胞因子,从而阻断炎症反应。 Objective To investigate the effect of continuous renal replacement therapy(CRRT) on the plasma cytokines in pa- tients with acute renal failure(ARF). Methods Forty-two patients with ARF were treated by CRRT. Levels of plasma cytokines inclu- ding tumor nectosis factor-α(TNF-α), interleakin-1β(IL-1β), inter leukin-6(IL-6), inter leukin-8 (IL-8) were detected by ELISA at 0, 4, 12, 24, 48 hours after treatment. The results were compared with those of the healthy people. Results The levels of serum TNF-α, IL-1β, IL-6, IL-8 in patients with ARF were markedly higher than those of the healthy controls ( P 〈 0.01). The cytokines started to reduce at 4 hours after CRRT and decreased to lowest levels at 12 hours after CRRT (P 〈 0. 01 ), then slightly elevated at 24- 48 hours after CRRT, but still lower than the levels before CRRT. Conclusion CRRT can effectively clear the inflammatory cyto- kines, therefore block the inflmnmatory reactions.
出处 《临床医学》 CAS 2012年第11期34-35,共2页 Clinical Medicine
关键词 连续性肾脏替代治疗 急性肾功能衰竭 细胞因子 炎症 Continuous renal replacement therapy Acute renal failure Cytokine Inflammatory
  • 相关文献

参考文献6

  • 1Joannidis M. Continuous renal replacement therapy in sepsis and mul- tisystem organ failure[J]. Semin Dial, 2009, 22(2) :160 -164.
  • 2Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal, replacement therapy in sepsis: The peak eoiacentra- tion hypothesis [ J ]. Artif Organs, 2003, 27 (9) :792 - 801.
  • 3~amashita A~, Tomisawa N. Membrane materials for blood purifica- tion in critical care[J]. Contrib Nephrol, 2010, 166:112 -118.
  • 4Seybold J, Thomas D, Witzenrath M, et al. Tumor necrosis factor-al- pha-dependent expression of phosphodiesterase 2 : role in endothelial hyperpermeability[ J]. Blood, 2005, 105 (9) : 3569 - 3576.
  • 5Cerda J, Ronco C. Modalities of continuous renal replacement thera- py : technical and clinical considerations [ J ]. Semin Dial, 2009, 22 (2) :114 -122.
  • 6Oda S, Sadahiro T, Hirayama Y, et al. Non-renal indications for con- tinuous renal replacement therapy: current status in Japan[ J]. Cont~ rib Nephrol, 2010, 166:47 - 53,.

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部